Loading market dashboard

Estimates, scoring, valuation assumptions, and peer comparison in one research surface.
MBX Biosciences, Inc. Common Stock · Forecast overview
Bars show expected revenue while the line tracks expected EPS.
| Period | Revenue avg | Revenue range | EBITDA | EPS avg | Analysts |
|---|---|---|---|---|---|
| Dec 2030 | $351.26M | $351.26M - $351.26M | $0.00 | -$0.601 | 7 |
| Dec 2029 | $130.36M | $130.36M - $130.36M | $0.00 | -$3.026 | 7 |
| Dec 2028 | $23.55M | $23.55M - $23.55M | $0.00 | -$4.168 | 8 |
| Dec 2027 | $0.00 | $0.00 - $0.00 | $0.00 | -$3.906 | 0 |
| Dec 2026 | $0.00 | $0.00 - $0.00 | $0.00 | -$2.802 | 0 |
| Dec 2025 | $0.00 | $0.00 - $0.00 | $0.00 | -$2.466 | 0 |
| Dec 2024 | $0.00 | $0.00 - $0.00 | $0.00 | -$11.519 | 0 |